{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:49Z","timestamp":1786119469093,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/mph.0b013e3181df5e5b","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T07:03:57Z","timestamp":1275548637000},"page":"e342-e346","source":"Crossref","is-referenced-by-count":14,"title":["Non-Hodgkin Lymphoma in a Patient With Cardiofaciocutaneous Syndrome"],"prefix":"10.1097","volume":"33","author":[{"given":"Akira","family":"Ohtake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Niihori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Kure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210227","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajmg.1320250303","article-title":"New multiple congenital anomaliesmental retardation syndrome with cardio-facio-cutaneous involvement--: the CFC syndrome.","volume":"25","author":"Reynolds","year":"1986","journal-title":"Am J Med Genet"},{"key":"R2-19-20210227","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.","volume":"38","author":"Niihori","year":"2006","journal-title":"Nat Genet"},{"key":"R3-19-20210227","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-0004.1997.tb02512.x","article-title":"Cardio-facio-cutaneous (CFC) syndromea distinct entity Report of three patients demonstrating the diagnostic difficulties in delineation of CFC syndrome.","volume":"52","author":"Wieczorek","year":"1997","journal-title":"Clin Genet"},{"key":"R4-19-20210227","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ajmg.a.31658","article-title":"Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.","volume":"143A","author":"Narumi","year":"2007","journal-title":"Am J Med Genet A"},{"key":"R5-19-20210227","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome.","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat Genet"},{"key":"R6-19-20210227","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat Genet"},{"key":"R7-19-20210227","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"key":"R8-19-20210227","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1926","article-title":"Germline gain-of-function mutations in SOS1 cause Noonan syndrome.","volume":"39","author":"Roberts","year":"2007","journal-title":"Nat Genet"},{"key":"R9-19-20210227","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome.","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat Genet"},{"key":"R10-19-20210227","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"key":"R11-19-20210227","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome.","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat Genet"},{"key":"R12-19-20210227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.497","article-title":"A restricted spectrum of NRAS mutations causes Noonan syndrome.","volume":"42","author":"Cirstea","year":"2010","journal-title":"Nat Genet"},{"key":"R13-19-20210227","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"R14-19-20210227","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nm0306-283","article-title":"Stops along the RAS pathway in human genetic disease.","volume":"12","author":"Bentires-Alj","year":"2006","journal-title":"Nat Med"},{"key":"R15-19-20210227","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RASMAPK syndromes: novel roles of the RAS pathway in human genetic disorders.","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum Mutat"},{"key":"R16-19-20210227","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.10241","article-title":"Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol.","volume":"108","author":"Gripp","year":"2002","journal-title":"Am J Med Genet"},{"key":"R17-19-20210227","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jmg.36.10.799","article-title":"Acute lymphoblastic leukaemia in a patient with cardiofaciocutaneous syndrome.","volume":"36","author":"van Den Berg","year":"1999","journal-title":"J Med Genet"},{"key":"R18-19-20210227","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MPH.0b013e3180547136","article-title":"Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.","volume":"29","author":"Makita","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"R19-19-20210227","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ajmg.a.31819","article-title":"Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome.","volume":"143A","author":"Al-Rahawan","year":"2007","journal-title":"Am J Med Genet A"},{"key":"R20-19-20210227","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pbc.21666","article-title":"Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Childrens Oncology Group.","volume":"51","author":"Smock","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R21-19-20210227","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2141.2007.06796.x","article-title":"Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.","volume":"139","author":"Mann","year":"2007","journal-title":"Br J Haematol"},{"key":"R22-19-20210227","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/sj.bjc.6601371","article-title":"BRAF mutations in non-Hodgkins lymphoma.","volume":"89","author":"Lee","year":"2003","journal-title":"Br J Cancer"},{"key":"R23-19-20210227","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.leu.2403201","article-title":"BRAF mutations in acute leukemias.","volume":"18","author":"Lee","year":"2004","journal-title":"Leukemia"},{"key":"R24-19-20210227","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/sj.leu.2403589","article-title":"Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia.","volume":"19","author":"Gustafsson","year":"2005","journal-title":"Leukemia"},{"key":"R25-19-20210227","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.leu.2403286","article-title":"BRAF gene is not mutated in mismatch repair-proficient or -deficient plasma cell dyscrasias.","volume":"18","author":"Velangi","year":"2004","journal-title":"Leukemia"},{"key":"R26-19-20210227","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2141.2003.04664.x","article-title":"Alterations of RAS signalling in Chinese multiple myeloma patients: absent BRAF and rare RAS mutations, but frequent inactivation of RASSF1A by transcriptional silencing or expression of a non-functional variant transcript.","volume":"123","author":"Ng","year":"2003","journal-title":"Br J Haematol"},{"key":"R27-19-20210227","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/sj.leu.2404009","article-title":"Mutations of genes in the receptor tyrosine kinase (RTK)RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.","volume":"19","author":"Christiansen","year":"2005","journal-title":"Leukemia"},{"key":"R28-19-20210227","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/leu.2008.14","article-title":"BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias.","volume":"22","author":"Davidsson","year":"2008","journal-title":"Leukemia"},{"key":"R29-19-20210227","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","article-title":"Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.","volume":"68","author":"Case","year":"2008","journal-title":"Cancer Res"},{"key":"R30-19-20210227","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.leu.2402787","article-title":"Mutation of BRAF is uncommon in AML FAB type M1 and M2.","volume":"17","author":"Smith","year":"2003","journal-title":"Leukemia"},{"key":"R31-19-20210227","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3324\/haematol.11493","article-title":"Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia.","volume":"92","author":"de Vries","year":"2007","journal-title":"Haematologica"},{"key":"R32-19-20210227","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jcp.21739","article-title":"Molecular bases of myelodysplastic syndromes: lessons from animal models.","volume":"219","author":"Komeno","year":"2009","journal-title":"J Cell Physiol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181df5e5b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:22:08Z","timestamp":1786040528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201112000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181df5e5b","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}